CD34 and acute promyelocytic leukemia: Furthermore, CD200 was identified as a novel LSC marker and highly expressed in both CD34+ and CD34– LSCs, including those with mutant NPM130, further validating our identification of leukemic stem-like cells in APL for its characteristic expression of CD200.